China Orphan drug Industry 2015 Deep Market Research Report

Table of Contents

Chapter One Industry Overview
1.1 Definition and Specifications of Orphan drug
1.2 Classification of Orphan drug
1.3 Applications of Orphan drug
1.4 Industry Chain Structure of Orphan drug
1.5 Industry Overview of Orphan drug
1.6 Industry Policy Analysis of Orphan drug
1.7 Industry News Analysis of Orphan drug
Chapter Two Manufacturing Cost Structure Analysis of Orphan drug
2.1 Bill of Materials (BOM) of Orphan drug
2.2 BOM Price Analysis of Orphan drug
2.3 Labor Cost Analysis of Orphan drug
2.4 Depreciation Cost Analysis of Orphan drug
2.5 Manufacturing Cost Structure Analysis of Orphan drug
2.6 Manufacturing Process Analysis of Orphan drug
Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of China Key Orphan drug Manufacturers in 2014
3.3 R&D Status and Technology Source of China Orphan drug Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of China Orphan drug Key Manufacturers in 2014
Chapter Four Production Analysis of Orphan drug by Regions, Technology, and Applications
4.1 China Production of Orphan drug by Regions (Key Provinces) 2010-2015
4.2 China Production of Orphan drug by Product Types 2010-2015
4.3 China Sales of Orphan drug by Applications 2010-2015
4.4 Price Analysis of China Orphan drug Key Manufacturers in 2015
4.5 China Capacity, Production, Price, Cost and Revenue of Orphan drug 2010-2015
4.6 China Supply, Import, Export and Consumption of Orphan drug 2010-2015
Chapter Five Sales and Revenue Analysis of Orphan drug by Regions
5.1 China Sales of Orphan drug by Regions 2010-2015
5.2 China Revenue of Orphan drug by Regions 2010-2015
5.3 China Price Analysis of Orphan drug Sales by Regions 2010-2015
5.4 China Price, Cost and Gross of Orphan drug 2010-2015
Chapter Six Analysis of Orphan drug Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Orphan drug 2010-2015
6.2 Production Sales Market Share Analysis of Orphan drug 2014-2015
6.3 Import, Export and Consumption of Orphan drug 2010-2015
6.4 Supply, Consumption and Shortage of Orphan drug 2010-2015
6.5 Import, Export and Consumption of Orphan drug 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Orphan drug 2010-2015
Chapter Seven Analysis of Orphan drug Industry Key Manufacturers
7.1 AGENUS
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 AGENUS SWOT Analysis
7.2 AOP ORPHAN
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 AOP ORPHAN SWOT Analysis
7.3 BIOGEN IDEC
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 BIOGEN IDEC SWOT Analysis
7.4 ELI LILLY
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 ELI LILLY SWOT Analysis
7.5 Celgene
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Celgene SWOT Analysis
7.6 MERCK
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 MERCK SWOT Analysis
7.7 ALEXION
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 ALEXION SWOT Analysis
7.8 Roche
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Roche SWOT Analysis
7.9 GENETHON
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 GENETHON SWOT Analysis
7.10 PFIZER
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 PFIZER SWOT Analysis
7.11 BRISTOL MYERS SQUIBB
7.11.1 Company Profile
7.11.2 Product Picture and Specifications
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 BRISTOL MYERS SQUIBB SWOT Analysis
7.12 GENZYME CORPORATION
7.12.1 Company Profile
7.12.2 Product Picture and Specifications
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 GENZYME CORPORATION SWOT Analysis
Chapter Eight Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Orphan drug Product Types
8.5 Market Share Analysis of Different Orphan drug Price Levels
8.6 Gross Margin Analysis of Different Orphan drug Applications
Chapter Nine Marketing Trader or Distributor Analysis of Orphan drug
9.1 Marketing Channels Status of Orphan drug
9.2 Traders or Distributors of Orphan drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Orphan drug
9.4 China Import, Export and Trade Analysis of Orphan drug
Chapter Ten Development Trend of Orphan drug Industry 2015-2020
10.1 Capacity and Production Overview of Orphan drug 2015-2020
10.2 Production Market Share by Product Types of Orphan drug 2015-2020
10.3 Sales and Sales Revenue Overview of Orphan drug 2015-2020
10.4 China Sales of Orphan drug by Applications 2015-2020
10.5 Import, Export and Consumption of Orphan drug 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Orphan drug 2015-2020
Chapter Eleven Industry Chain Suppliers of Orphan drug with Contact Information
11.1 Major Raw Materials Suppliers of Orphan drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Orphan drug with Contact Information
11.3 Major Players of Orphan drug with Contact Information
11.4 Key Consumers of Orphan drug with Contact Information
11.5 Supply Chain Relationship Analysis of Orphan drug
Chapter Twelve New Project Investment Feasibility Analysis of Orphan drug
12.1 New Project SWOT Analysis of Orphan drug
12.2 New Project Investment Feasibility Analysis of Orphan drug
Chapter Thirteen Conclusion of the China Orphan drug Industry Report 2015

List of Tables and Figures

Figure Picture of Orphan drug
Table Product Specifications of Orphan drug
Table Classification of Orphan drug
Figure China Sales Market Share of Orphan drug by Product Types in 2014
Table Applications of Orphan drug
Figure China Sales Market Share of Orphan drug by Applications in 2014
Figure Industry Chain Structure of Orphan drug
Table China Industry Overview of Orphan drug
Table Industry Policy of Orphan drug
Table Industry News List of Orphan drug
Table Bill of Materials (BOM) of Orphan drug
Table Bill of Materials (BOM) Price of Orphan drug
Table Labor Cost of Orphan drug
Table Depreciation Cost of Orphan drug
Table Manufacturing Cost Structure Analysis of Orphan drug in 2014
Figure Manufacturing Process Analysis of Orphan drug
Table Capacity (K Tonne) and Commercial Production Date of China Orphan drug Key Manufacturers in 2014
Table Manufacturing Plants Distribution of China Key Orphan drug Manufacturers in 2014
Table R&D Status and Technology Source of China Orphan drug Key Manufacturers in 2014
Table Raw Materials Sources Analysis of China and China Orphan drug Key Manufacturers in 2014
Table China Production of Orphan drug by Regions 2010-2015 (K Tonne)
Table China Production Market Share of Orphan drug by Regions 2010-2015 (%)
Figure China Production Market Share of Orphan drug by Regions in 2014
Figure China Production Market Share of Orphan drug by Regions in 2015
Table China Production of Orphan drug by Product Types in 2010-2015 (K Tonne)
Table China Production Market Share of Orphan drug by Product Types in 2010-2015 (%)
Figure China Production Market Share of Orphan drug by Technology in 2014
Figure China Production Market Share of Orphan drug by Technology in 2015
Figure China Sales of Orphan drug by Applications 2010-2015 (K Tonne)
Table China Production Market Share of Orphan drug by Applications 2010-2015 (%)
Figure China Production Market Share of Orphan drug by Applications in 2014
Figure China Production Market Share of Orphan drug by Applications in 2015
Table Price Comparison of China Orphan drug Key Manufacturers in 2015 (USD/Tonne)
Table China Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne) and Revenue (M USD) of Orphan drug 2010-2015
Table China Supply, Import, Export and Consumption of Orphan drug 2010-2015 (K Tonne)
Table China Sales of Orphan drug by Regions 2010-2015 (K Tonne)
Table China Sales Market Share of Orphan drug by Regions 2010-2015 (%)
Figure China Sales of Orphan drug by Regions (Beijing, Guangdong, Shanghai, etc.) in 2014 (K Tonne)
Figure China Sales of Orphan drug by Regions (Beijing, Guangdong, Shanghai, etc.) in 2015 (K Tonne)
Table China Revenue of Orphan drug by Regions 2010-2015 (M USD)
Table China Revenue of Orphan drug by Regions 2010-2015 (%)
Figure China Revenue of Orphan drug by Regions in 2014 (%)
Figure China Revenue of Orphan drug by Regions in 2015 (%)
Table Sales Price of Orphan drug by Regions 2010-2015 (USD/Tonne)
Table China Price Analysis of Orphan drug 2010-2015 (USD/Tonne)
Table China Cost Analysis of Orphan drug 2010-2015 (USD/Tonne)
Table China Gross Analysis of Orphan drug 2010-2015
Table China and Major Manufacturers Capacity of Orphan drug 2010-2015 (K Tonne)
Table China Capacity Market Share of Major Orphan drug Manufacturers 2010-2015 (%)
Table China and Major Manufacturers Production of Orphan drug 2010-2015 (K Tonne)
Table China Production Market Share of Major Orphan drug Manufacturers 2010-2015 (%)
Table China and Major Manufacturers Sales of Orphan drug 2010-2015 (K Tonne)
Table China Sales Market Share of Major Orphan drug Manufacturers 2010-2015 (%)
Table China and Major Manufacturers Sales Revenue of Orphan drug 2010-2015 (M USD)
Table China Sales Revenue Market Share of Major Orphan drug Manufacturers 2010-2015 (%)
Figure China Capacity (K Tonne), Production (K Tonne) and Growth Rate of Orphan drug 2010-2015
Figure China Capacity Utilization Rate of Orphan drug 2010-2015
Figure China Sales Revenue (M USD) and Growth Rate of Orphan drug 2010-2015
Figure China Production Market Share of Major Orphan drug Manufacturers in 2014
Figure China Production Market Share of Major Orphan drug Manufacturers in 2015
Figure China Sales Market Share of Major Orphan drug Manufacturers in 2014
Figure China Sales Market Share of Major Orphan drug Manufacturers in 2015
Table China Import, Export and Consumption of Orphan drug 2010-2015 (K Tonne)
Table China and Major Manufacturers Local Sales Export Import of Orphan drug 2010-2015 (K Tonne)
Table China Supply, Consumption and Shortage of Orphan drug 2010-2015 (K Tonne)
Table China Import, Export and Consumption of Orphan drug 2010-2015 (K Tonne)
Table Price of China Orphan drug Major Manufacturers 2010-2015 (USD/Tonne)
Table Gross Margin of China Orphan drug Major Manufacturers 2010-2015
Table China and Major Manufacturers Revenue of Orphan drug 2010-2015 (M USD)
Table China Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Revenue (M USD) and Gross Margin of Orphan drug 2010-2015
Table AGENUS Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of AGENUS
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of AGENUS 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of AGENUS 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of AGENUS 2010-2015
Table AGENUS Orphan drug SWOT Analysis
Table AOP ORPHAN Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of AOP ORPHAN
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of AOP ORPHAN 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of AOP ORPHAN 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of AOP ORPHAN 2010-2015
Table AOP ORPHAN Orphan drug SWOT Analysis
Table BIOGEN IDEC Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of BIOGEN IDEC
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of BIOGEN IDEC 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of BIOGEN IDEC 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of BIOGEN IDEC 2010-2015
Table BIOGEN IDEC Orphan drug SWOT Analysis
Table ELI LILLY Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of ELI LILLY
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of ELI LILLY 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of ELI LILLY 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of ELI LILLY 2010-2015
Table ELI LILLY Orphan drug SWOT Analysis
Table Celgene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of Celgene
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of Celgene 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of Celgene 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of Celgene 2010-2015
Table Celgene Orphan drug SWOT Analysis
Table MERCK Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of MERCK
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of MERCK 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of MERCK 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of MERCK 2010-2015
Table MERCK Orphan drug SWOT Analysis
Table ALEXION Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of ALEXION
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of ALEXION 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of ALEXION 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of ALEXION 2010-2015
Table ALEXION Orphan drug SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of Roche
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of Roche 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of Roche 2010-2015
Table Roche Orphan drug SWOT Analysis
Table GENETHON Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of GENETHON
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of GENETHON 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of GENETHON 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of GENETHON 2010-2015
Table GENETHON Orphan drug SWOT Analysis
Table PFIZER Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of PFIZER
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of PFIZER 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of PFIZER 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of PFIZER 2010-2015
Table PFIZER Orphan drug SWOT Analysis
Table BRISTOL MYERS SQUIBB Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of BRISTOL MYERS SQUIBB
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of BRISTOL MYERS SQUIBB 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of BRISTOL MYERS SQUIBB 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of BRISTOL MYERS SQUIBB 2010-2015
Table BRISTOL MYERS SQUIBB Orphan drug SWOT Analysis
Table GENZYME CORPORATION Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Orphan drug Picture and Specifications of GENZYME CORPORATION
Table Orphan drug Capacity (K Tonne), Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Gross (USD/Tonne), Revenue (M USD) and Gross Margin of GENZYME CORPORATION 2010-2015
Figure Orphan drug Capacity (K Tonne), Production (K Tonne) and Growth Rate of GENZYME CORPORATION 2010-2015
Figure Orphan drug Production (K Tonne) and China Market Share of GENZYME CORPORATION 2010-2015
Table GENZYME CORPORATION Orphan drug SWOT Analysis
Table Orphan drug Price by Regions 2010-2015
Table Orphan drug Price by Product Types 2010-2015
Table Orphan drug Price by Company 2010-2015
Table Orphan drug Gross Margin by Company 2010-2015
Table Price Comparison of Orphan drug by Regions 2010-2015 (USD/Tonne)
Table Price of Different Orphan drug Product Types (USD/Tonne)
Table Market Share of Different Orphan drug Price Level
Table Gross Margin of Different Orphan drug Applications
Table Marketing Channels Status of Orphan drug
Table Traders or Distributors of Orphan drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Orphan drug (USD/Tonne)
Table China Import, Export, and Trade of Orphan drug (K Tonne)
Figure China Capacity (K Tonne), Production (K Tonne) and Growth Rate of Orphan drug 2015-2020
Figure China Capacity Utilization Rate of Orphan drug 2015-2020
Table China Orphan drug Production by Product Types 2010-2015 (K Tonne)
Table China Orphan drug Production Market Share by Product Types 2010-2015 (%)
Figure China Production Market Share of Orphan drug by Technology in 2020
Figure China Sales (K Tonne) and Growth Rate of Orphan drug 2015-2020
Figure China Sales Revenue (Million USD) and Growth Rate of Orphan drug 2015-2020
Figure China Sales of Orphan drug by Applications 2015-2020 (K Tonne)
Table China Production Market Share of Orphan drug by Applications 2015-2020 (%)
Figure China Production Market Share of Orphan drug by Applications in 2020
Table China Production, Import, Export and Consumption of Orphan drug 2015-2020 (K Tonne)
Table China Production (K Tonne), Price (USD/Tonne), Cost (USD/Tonne), Revenue (M USD) and Gross Margin of Orphan drug 2015-2020
Table Major Raw Materials Suppliers of Orphan drug with Contact Information
Table Manufacturing Equipment Suppliers of Orphan drug with Contact Information
Table Major Players of Orphan drug with Contact Information
Table Key Consumers of Orphan drug with Contact Information
Table Supply Chain Relationship Analysis of Orphan drug
Table New Project SWOT Analysis of Orphan drug
Table New Project Investment Feasibility Analysis of Orphan drug
Table Part of Interviewees Record List

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.